ReviewBiological trace element research2025
Is There Any Role of Zinc and Copper in Severity and Progression of Osteoarthritis? A Review.
Review in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is one of the most prevalent chronic diseases of the aging population, with an incidence of more than 250 million affected people and annual treatment costs exceeding $80 billion. Osteoarthritis involves pain, stiffness, reduced mobility, and swelling of the joints due to cartilage wear and tear and inflammation, which results in a broad system affecting the joints. This review focuses on the relationship between zinc and copper and the effects of these minerals on osteoarthritis. Osteoarthritis is a degenerative disease that currently affects millions of people and is characterized by the degradation of joint cartilage and inflammation. Zinc is crucial to the development of healthy cells, including cartilage, and copper keeps cartilage in balance and improves the immune response. If these elements are imbalanced, then symptoms of osteoarthritis may worsen, and studies have revealed that people with osteoarthritis exhibit increased levels of copper, which is the active factor in inflammation and cartilage breakdown. In osteoarthritis patients, the level of zinc is decreased, yet it plays an important role in bone and cartilage formation. Zinc and copper are interrelated because zinc has antioxidant properties, while copper might have a detrimental effect on cell injury. More investigations must be conducted on the therapeutic aspects of these processes and on how to improve the treatment of osteoarthritis. Knowledge of these relationships could allow for enhanced diagnosis, proper treatment, and therapy for people with osteoarthritis, hence enhancing quality of life.
Indexed as
Identifiers
40293684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.